Sofinnova Partners Announces Myricx Bio Agrees to Be Acquired by Novartis
PARIS & LONDON, July 06, 2026--Sofinnova Partners, a leading European life sciences venture capital firm, today announced that its portfolio company Myricx Bio ("Myricx") has reached agreement to be acquired by Novartis, for up to $1.5 billion includ...